Navigation Links
The Valley Hospital and Webmedx Partner to Reduce DNFB, Improve Clinical Documentation and Automate Quality Reporting
Date:2/10/2011

l documentation partner. "We selected Webmedx for their advanced technology infrastructure, extremely rapid report turnaround times and reputation for delivering on promises," Haspel mentions. The company was tied for first place in keeping promises, according to the *KLAS 2010 "Transcription Services: Competition, Technology, and Consolidation" report. Rated #1 in their category for professional services by KLAS two years in a row, Webmedx received the highest overall service score ever in 2009, and an even higher score of 92.3% in the "2010 Top 20 Best in KLAS Awards" report available at: www.KLASResearch.com. This achievement has never been equaled in the history of KLAS Research for this category.

An advanced NLP, text and data mining system, QualityAnalytics identifies and abstracts discrete information concurrently from narrative, free-text documents and other clinical systems, and converts it to actionable data for a variety of secondary uses. Discrete data derived from narrative reports, Narradata™, can be used for upload to the EHR, clinical documentation improvement (CDI), coding reviews, RAC audits, patient safety, core measures monitoring and more. Users conduct ad hoc searches on virtually any phrase or diagnostic code using the NLP engine, without the need for custom reports or IT department intervention.

"The future of Webmedx is clinical document intelligence through searchable text and narrative informatics," mentions Sean Carroll, CEO, Webmedx. "We are honored to partner with The Valley Hospital in these three clinical documentation areas," he concludes.

About WebmedxWebmedx, Inc. is the 3rd largest supplier of transcription and editing services and clinical documentation technology for hospitals and clinics nationall
'/>"/>

SOURCE Webmedx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Jordan Valley Semiconductors (JVS) Targets Quality Control in LED and Compound Semiconductor Manufacturing
4. Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center
5. Diablo Valley Oncology First Cancer Center in Northern California to Offer NEW Radiation Device
6. Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank
7. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
8. Salinas Valley Memorial Completes Successful Implant of Cardiac Monitor and Alert System
9. Special Event Providing Exclusive Access to Shanghais Booming Zhangjiang Pharma Valley Added to Agenda of First Annual SBS China Conference
10. Applied Seals North America Bolsters Engineering and Applications Services in Silicon Valley With Addition of Design Engineer
11. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... to be held March 8-11, 2015, in ... Sapirstein , Chief Executive Officer, will provide an overview ... will be available to participate in one-on-one meetings with ...
(Date:3/5/2015)... , March 5, 2015 According ... Market by Product (Systems and Disposables), by Type (Invasive, ... , Home and Ambulatory Sites) - Analysis & Global ... Market is expected to reach $1,107.4 Million by 2019 ... grow at a CAGR of 4.5% during the forecast ...
(Date:3/5/2015)... Ascendis Pharma A/S, a clinical stage ... to address significant unmet medical needs, today announced ... 2015 conference being held at the San Diego ... Thursday, March 5, 2015 during the Pediatric Endocrinology—Clinical/Translational ... and are titled: TransCon ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4Ascendis Pharma to Present at ENDO 2015 2
... ... today that new data, including a late-breaking presentation on Tasigna® ... leukemia, demonstrate the strength of the company,s hematology portfolio in ... at the 51st American Society of Hematology (ASH) Annual Meeting ...
... 1 Patient Safety Technologies, Inc. (OTC Bulletin Board: ... Rose, CPA(PA), to the position of Chief Financial Officer, ... has been acting CFO since 2008. Prior to ... President Finance, Chief Financial Officer, Treasurer and Corporate Secretary ...
Cached Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2
(Date:3/5/2015)... 05, 2015 A Bakersfield, Calif. state court ... trial awarding the plaintiff Coleen M. Perry a total ... of a TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, ... Cartmell , a partner at Wagstaff & Cartmell ... the plaintiff, along with Rich Freese and Tim Goss of ...
(Date:3/5/2015)... Rhode Island Medical Imaging (RIMI) was pleased ... to support the Providence College (PC) women’s basketball program’s fight ... of the ‘Think Pink’ uniforms, which were worn during the ... DePaul University at Alumni Hall/Mullaney Gymnasium in Providence, R.I. ... the PC women’s basketball’s ‘Pink Out’ event,” said Dr. Scott ...
(Date:3/5/2015)... March 05, 2015 In honor of ... shatter myths about drug and alcohol abuse in schools ... a Fact Sheet with information on some of the ... 2010 by the National Institute on Drug Abuse, this ... aims to counteract the illusions that teens and young ...
(Date:3/5/2015)... Los Angeles, Calif. (PRWEB) March 05, 2015 ... company and the leader in the natural products coffee ... Coffee at Natural Products Expo West in Anaheim, Calif. ... Califia’s home café concept, Califia Café, which democratizes the ... drinkers all the ingredients they need to become their ...
(Date:3/5/2015)... Dr. Jonathan Glashow a board certified ... been named by Castle Connolly as a ... Glashow has been selected by Castle Connolly Medical Ltd. ... specialty care doctors in the tri-state metropolitan New York ... which carefully screens and selects doctors through a rigorous ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2
... a study done by Kate Rittenhouse-Olson, Ph.D., the monoclonal antibody ... shown to extend// significantly the survival of mice with human ... antibody inhibits the cancer's spread to the lungs in the ... study were published in the November 2006 issue of Journal ...
... of height which happens as people catch up with age is ... which could have major repercussions on health, increasing the chances of ... of about 3 centimeters or more in height of men as ... compared to men who lose less than a centimeter. This risk ...
... Researchers from University of Queensland believe that the conotoxins ... treatment for sufferers from chronic pain//. This treatment could ... ,Researchers say that the toxin, snail uses ... the severe side effects usually caused by other pain ...
... say that they are not abandoning their quest of finding ... the death of new cholesterol drugs manufactured// by Pfizer. Reducing ... cardiology in recent years, but boosting its counterpart, HDL, also ... market the new drug with Lipitor, a cholesterol-lowering statin that ...
... will now be made more easily available to critically ill ... proposition that will enable patients// who are extremely ill to ... other options. ,The FDA has announced that they ... drugs to be made available to needy individuals .They will ...
... nosed, bleary- eyed Britons, relief from hay fever may ... pill, designed to prevent// allergic reactions like a running nose, itching ... ,The vaccine pill contains small amounts of Timothy grass pollen; main ... weeks before hay fever season. ,This pill follows the ...
Cached Medicine News:Health News:Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies 2Health News:Revolutionary Pill Promises Relief for Hay Fever Sufferers 2
Angled 45 degree shafts with tying platform. Wide serrated handle with dull finish. Overall length 4.2 inches....
Straight shafts with 6 mm tying platform and crisscross serrated tips. Round knurled handle with polished finish. Overall length 4.5 inches....
Curved shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches....
Ultra-fine tying platform with round knurled handle for fingertip rotational control. Straight shafts. Overall length 3.9 inches....
Medicine Products: